Toxicological Sciences 55, 303-310 (2000)
Copyright © 2000 by the Society of Toxicology
Choline Supplementation Inhibits Diethanolamine-Induced Morphological Transformation in Syrian Hamster Embryo Cells: Evidence for a Carcinogenic Mechanism
Human and Environmental Safety Division, Miami Valley Laboratories, Procter and Gamble Company, Cincinnati, Ohio 45253
DEA, an amino alcohol, and its fatty acid condensates are widely used in commerce. DEA is hepatocarcinogenic in mice, but shows no evidence of mutagenicity or clastogenicity in a standard testing battery. However, it increased the number of morphologically transformed colonies in the Syrian hamster embryo (SHE) cell morphologic transformation assay. The goal of this work was to test the hypothesis that DEA treatment causes morphologic transformation by a mechanism involving altered cellular choline homeostasis. As a first step, the ability of DEA to disrupt the uptake and intracellular utilization of choline was characterized. SHE cells were cultured in medium containing DEA (500 µg/ml), and 33P-phosphorus or 14C-choline was used to label phospholipid pools. After 48 h, SHE cells were harvested, lipids were extracted, and radioactive phospholipids were quantified by autoradiography after thin layer chromatographic separation. In control cells, phosphatidylcholine (PC) was the major phospholipid, accounting for 43 ± 1% of total phospholipid synthesis. However, with DEA treatment, PC was reduced to 14 ± 2% of total radioactive phospholipids. DEA inhibited choline uptake into SHE cells at concentrations 
50 µg /ml, reaching a maximum 80% inhibition at 250–500 µg/ml. The concentration dependence of the inhibition of PC synthesis by DEA (0, 10, 50, 100, 250, and 500 µg/ml) was determined in SHE cells cultured over a 7-day period under the conditions of the transformation assay and in the presence or absence of excess choline (30 mM). DEA treatment decreased PC synthesis at concentrations 100 µg/ml, reaching a maximum 60% reduction at 500 µg/ml. However, PC synthesis was unaffected when DEA-treated cells were cultured with excess choline. Under 7-day culture conditions, 14C-DEA was incorporated into SHE lipids, and this perturbation was also inhibited by choline supplementation. Finally, DEA (10–500 µg/ml) transformed SHE cells in a concentration-dependent manner, whereas with choline supplementation, no morphologic transformation was observed. Thus, DEA disrupts intracellular choline homeostasis by inhibiting choline uptake and altering phospholipid synthesis. However, excess choline blocks these biochemical effects and inhibits cell transformation, suggesting a relationship between the two responses. Overall, the results provide a plausible mechanism to explain the morphologic transformation observed with DEA and suggest that the carcinogenic effects of DEA may be caused by intracellular choline deficiency.
Key Words: carcinogenesis; cell transformation; choline deficiency; diethanolamine.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. D. Niculescu, R. Wu, Z. Guo, K. A. da Costa, and S. H. Zeisel Diethanolamine Alters Proliferation and Choline Metabolism in Mouse Neural Precursor Cells Toxicol. Sci., April 1, 2007; 96(2): 321 - 326. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Kamendulis and J. E. Klaunig Species Differences in the Induction of Hepatocellular DNA Synthesis by Diethanolamine Toxicol. Sci., October 1, 2005; 87(2): 328 - 336. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. T. Stott, B. J. Radtke, V. A. Linscombe, M.-H. Mar, and S. H. Zeisel Evaluation of the Potential of Triethanolamine to Alter Hepatic Choline Levels in Female B6C3F1 Mice Toxicol. Sci., June 1, 2004; 79(2): 242 - 247. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. D. Lehman-McKeeman, E. A. Gamsky, S. M. Hicks, J. D. Vassallo, M.-H. Mar, and S. H. Zeisel Diethanolamine Induces Hepatic Choline Deficiency in Mice Toxicol. Sci., May 1, 2002; 67(1): 38 - 45. [Abstract] [Full Text] [PDF]
|
|